When evaluating where to buy CJC online for institutional or laboratory research, verification of chemical identity, purity, and bio-burden is critical. PX1 Research supplies high-purity, synthetic CJC-1295 compounds featuring verified lot-specific Certificate of Analysis (COA) reports, HPLC chromatograms, and mass spectrometry data for controlled in vitro and preclinical research applications.
When evaluating where to buy CJC online for institutional or laboratory research, verification of chemical identity, purity, and bio-burden is critical. PX1 Research supplies high-purity, synthetic CJC-1295 compounds featuring verified lot-specific Certificate of Analysis (COA) reports, HPLC chromatograms, and mass spectrometry data for controlled in vitro and preclinical research applications.
Researchers seeking to buy CJC online must carefully evaluate supplier credentials, analytical rigor, and chemical synthesis standards. CJC-1295 is a synthetic tetrasubstituted 29-amino acid peptide analog of growth hormone-releasing hormone (GHRH). In preclinical research environments, it is investigated for its ability to selectively bind to the GHRH receptor on anterior pituitary somatotrophs, stimulating biosynthesizing pathways without causing off-target prolactin or cortisol spikes.
Due to variations in chemical synthesis, raw materials, and purification methodologies across global vendors, acquiring research-grade CJC requires strict adherence to quality assurance metrics. PX1 Research manufactures research compounds within ISO 17025 accredited and GMP-compliant facilities in the United States, providing complete lot traceability and independent analytical verification for every batch distributed to academic, clinical, and corporate laboratories.
When browsing options to buy CJC online, investigators frequently encounter two primary structural variants: CJC-1295 with Drug Affinity Complex (DAC) and CJC-1295 without DAC (commonly designated as Mod GRF 1-29). Both analogs represent modified sequences of native GHRH(1-29), incorporating specific amino acid substitutions at positions 2, 8, 15, and 27 to enhance resistance to enzymatic cleavage by dipeptidyl peptidase IV (DPP-IV).
The primary structural differentiator between these two compounds lies in the addition of the reactive maleimide moiety in CJC-1295 DAC. This functional group forms a stable covalent bond with endogenous serum albumin following administration in preclinical rodent or non-human primate models, significantly extending its half-life from minutes to several days. Conversely, CJC-1295 No DAC lacks this albumin-reactive tail, maintaining a shorter, pulsatile pharmacokinetic profile that closely mimics endogenous GHRH secretion patterns in laboratory assays. Selecting between these variants depends on whether the investigative protocol requires continuous baseline stimulation or pulsatile receptor engagement.
Preclinical investigations demonstrate that CJC-1295 functions as a selective GHRH receptor agonist. Upon binding to GHRH receptors expressed on pituitary somatotrophs, the peptide activates the G-protein-coupled receptor (GPCR) signal transduction pathway. This activation triggers adenylyl cyclase, elevating intracellular cyclic adenosine monophosphate (cAMP) and initiating protein kinase A (PKA) signaling cascades that promote growth hormone gene expression and exocytosis.
In vivo rodent models indicate that sustained activation of this pathway leads to elevated circulating growth hormone and insulin-like growth factor 1 (IGF-1) concentrations without disrupting normal feedback inhibition loops. Researchers utilize these models to examine cellular proliferation, tissue regeneration mechanisms, lipid oxidation pathways, and nitrogen retention dynamics. Reviewing our comprehensive peptide analytical hub provides further context into the specific binding affinities and signaling kinetics documented across published preclinical literature.
Procuring synthetic peptides online introduces risk if vendors lack transparent analytical documentation. To ensure high experimental reproducibility, laboratories must demand robust lot-specific testing prior to procurement. Substandard peptides containing truncated sequences, residual reagents, or heavy metals can confound experimental metrics and yield non-reproducible data.
PX1 Research establishes a standardized benchmark for peptide quality by pairing every lot with independent verification. When you purchase from our comprehensive catalog of research peptides, each vial is traceably linked to its corresponding analytical documentation. Our quality control framework mandates verification via high-performance liquid chromatography (RP-HPLC) to confirm purity profiles exceed 99%, alongside liquid chromatography-mass spectrometry (LC-MS) to confirm exact molecular weight and sequence integrity.
High-Performance Liquid Chromatography (RP-HPLC) is the gold standard for assessing chemical purity in synthetic peptides. During RP-HPLC analysis, the CJC-1295 sample is passed through a hydrophobic stationary phase under high pressure. Impurities, synthesis side-products, and deletion sequences elute at distinct retention times, generating clear chromatographic peaks. PX1 Research guarantees that all CJC batches display a single dominant peak accounting for greater than 98–99% of total integrated peak area.
Mass Spectrometry (MS) complements HPLC by confirming structural identity. By measuring the mass-to-charge ratio (m/z) of ionized peptide molecules, LC-MS verifies that the synthesized chain precisely matches the theoretical monoisotopic mass of CJC-1295 (C152H252N44O42 for CJC-1295 with DAC, MW 3367.9 g/mol; or C152H252N44O42 derivatives). This dual-testing approach eliminates ambiguity regarding compound identity, ensuring that researchers receive exact chemical structures for their target assays.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from Gram-negative bacterial cell walls—pose a severe threat to cell culture experiments and animal study models. Elevated endotoxin levels induce non-specific inflammatory responses, activating NF-κB pathways and altering cytokine expression profiles, which can mask the true pharmacological effects of the compound under study.
PX1 Research conducts stringent Limulus Amebocyte Lysate (LAL) testing on all lot preparations to guarantee endotoxin thresholds strictly below standard research limits (<0.01 EU/mg). Products manufactured in our US-based, GMP-compliant facilities are processed under strict aseptic conditions, stored in sterile borosilicate glass vials, and lyophilized to preserve stability while eliminating microbial contamination risks.
In secretagogue receptor research, scientists frequently evaluate CJC-1295 alongside other growth hormone-releasing compounds to map synergistic or differential receptor responses. While CJC-1295 targets the GHRH receptor pathway, ghrelin receptor agonists activate the growth hormone secretagogue receptor (GHSR-1a) through a distinct, non-overlapping intracellular pathway.
Comparative studies often pair CJC-1295 No DAC with selective GHSR agonists like Ipamorelin to investigate dual-receptor co-stimulation in vitro. Alternatively, investigators may compare the prolonged pharmacokinetic profile of CJC-1295 against short-acting secretagogues such as GHRP-6 or native-sequence analogs like Sermorelin. Analyzing these compounds side-by-side allows researchers to assess differences in receptor desensitization, half-life, somatotroph recruitment, and downstream IGF-1 transcription rates.
CJC-1295 is supplied as a sterile, lyophilized (freeze-dried) powder to maximize shelf stability during transit and storage. Upon delivery, unopened vials should be stored in a temperature-controlled environment at -20°C or -80°C, protected from light and moisture exposure. Lyophilized peptides remain stable under these conditions for up to 24 months.
For laboratory reconstitution, researchers should utilize sterile bacteriostatic water (containing 0.9% benzyl alcohol) or sterile normal saline, depending on the requirements of the specific cell culture or animal model assay. Reconstitution should be performed slowly by directing the solvent down the glass wall of the vial, followed by gentle swirling. Aggressive vortexing must be avoided to prevent shear-induced mechanical degradation of the tertiary peptide structure. Once reconstituted, solutions should be aliquoted to avoid repeated freeze-thaw cycles and maintained at 2°C to 8°C for short-term experimental protocols.
Academic institutions, biotechnology research organizations, and contract research organizations (CROs) requiring ongoing supplies of CJC-1295 can establish streamlined procurement pathways. PX1 Research supports institutional buying workflows by providing bulk volume tiers, lot-reservation options, and dedicated account management through our wholesale lab accounts portal.
All orders are processed and shipped direct from our dual distribution hubs in California and Arizona, offering same-day dispatch for orders placed before standard cutoff times (Monday through Friday). This US-based logistics infrastructure ensures rapid cold-chain delivery, minimizing transit times and preserving peptide integrity for sensitive analytical procedures.
What is the primary difference between CJC-1295 with DAC and CJC-1295 without DAC?
CJC-1295 with DAC incorporates a Drug Affinity Complex (maleimide moiety) that enables covalent binding to endogenous serum albumin, extending its biological half-life to several days in animal models. CJC-1295 without DAC (Mod GRF 1-29) lacks this complex, resulting in a significantly shorter half-life (approx. 30 minutes) suited for studying pulsatile GHRH receptor activity.
How can I verify the purity of CJC-1295 purchased online from PX1 Research?
PX1 Research provides a lot-specific Certificate of Analysis (COA) with every shipment. Purity is independently verified via RP-HPLC (confirming >98-99% purity) and LC-MS (confirming exact molecular mass). All analytical documentation is accessible directly through our site or upon request.
Is CJC-1295 supplied for human consumption or medical use?
No. CJC-1295 supplied by PX1 Research is strictly designated for laboratory research use only (RUO). It is not intended for human or veterinary diagnostic, therapeutic, or clinical applications.
What are the recommended storage conditions for lyophilized CJC-1295?
Unreconstituted, lyophilized CJC-1295 should be stored at -20°C or -80°C in a dry, dark environment to maintain long-term chemical stability. Under these conditions, the compound remains stable for up to 24 months.
What solvent should be used for reconstituting CJC-1295 in laboratory settings?
Laboratory protocols typically reconstitute lyophilized CJC-1295 using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile 0.9% sodium chloride solution, depending on the specific in vitro or in vivo experimental design.
What are the endotoxin limits for PX1 Research CJC-1295?
All batches undergo rigorous Limulus Amebocyte Lysate (LAL) assay testing to ensure endotoxin levels remain strictly below <0.01 EU/mg, preventing confounding inflammatory responses in cell cultures or animal studies.
How fast does PX1 Research ship CJC-1295 orders?
Orders placed Monday through Friday before our daily cutoff time ship same-day directly from our centralized distribution facilities located in California and Arizona.
Can institutions request bulk pricing or custom lot reservations?
Yes. Principal investigators, universities, and commercial research facilities can set up dedicated institutional accounts through our wholesale portal to secure lot-reserved batches and volume-based pricing structures.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.